News & Analysis on Clinical Trial Services & Contract Research And Development
The first new leukaemia treatment approved specifically for children in more than a decade was approved as Ash Stevens are to manufacture Clofarabine, the active ingredient in Clolar, used to treat acute lymphoblastic leukaemia (ALL).
Pharmaceutical companies are set to face stiff competition, as generic forms of best-selling biologic drugs will capture a significant market share. The expiration of drug patents, which expire within the next few years, opens up a new market for API...
TransPharma Medical has entered into collaboration with Teva Pharmaceutical to develop transdermal drug delivery systems. The deal aims to research and develop transdermal delivery of therapeutic drugs such as high molecular weight proteins.
A new method to produce paclitaxel, the potent anti-tumour drug from yew needles has been discovered which provides a solution to the problem of finding a viable source of the raw material at a relatively low cost.
Technology used to enhance a mammalian cell based protein in pharmaceutical production as well as the creation of new production cell lines is the subject of collaboration between Pfizer and Sangamo BioSciences.